Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | McClellan Michael James | EVP, Chief Financial Officer | Nov 05, 2019 | Sale | $8.83 | 242 | 2,138 | 15,898 | Nov 06, 2019, 06:46 AM | |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | McClellan Michael James | EVP, Chief Financial Officer | Sep 18, 2019 | Sale | $7.83 | 1,406 | 11,011 | 15,445 | Sep 20, 2019, 07:17 AM | |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | McClellan Michael James | EVP, Chief Financial Officer | Mar 18, 2019 | Sale | $16.63 | 230 | 3,824 | 12,760 | Mar 19, 2019, 08:08 AM | |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | McClellan Michael James | EVP, Chief Financial Officer | Mar 04, 2019 | Sale | $16.88 | 363 | 6,129 | 12,330 | Mar 05, 2019, 07:28 AM | |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | McClellan Michael James | EVP, Chief Financial Officer | Nov 05, 2018 | Sale | $22.73 | 346 | 7,865 | 11,644 | Nov 07, 2018, 06:38 AM | |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | McClellan Michael James | EVP, Chief Financial Officer | Mar 19, 2018 | Sale | $17.88 | 287 | 5,131 | 11,295 | Mar 20, 2018, 04:10 PM | |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | McClellan Michael James | EVP, Chief Financial Officer | Mar 05, 2018 | Option Exercise | $19.38 | 455 | 8,818 | 10,922 | Mar 06, 2018, 04:16 PM |